(R,R)-Tetrahydrochrysene (also known as (R,R)-THC) is a synthetic, nonsteroidal compound that binds selectively to estrogen receptors (ERs). It functions as an agonist of the estrogen receptor alpha (ERα) and as an antagonist of the estrogen receptor beta (ERβ). Because of its selective receptor activity, it is primarily used in scientific research to investigate estrogen signaling pathways and the differential roles of ER subtypes in various tissues.
(R,R)-Tetrahydrochrysene is a stereoisomer with two chiral centers, which confer its specific receptor selectivity. As a selective estrogen receptor modulator (SERM), it displays dual behavior depending on the receptor subtype it binds:
Acts as an agonist at ERα, mimicking the action of endogenous estrogens such as estradiol.
Acts as an antagonist at ERβ, blocking the receptor and inhibiting downstream estrogen-mediated gene expression.
This dual behavior allows researchers to dissect the roles of ERα and ERβ in biological processes, such as cell proliferation, apoptosis, metabolism, and reproductive physiology.
(R,R)-Tetrahydrochrysene binds to the ligand-binding domain (LBD) of estrogen receptors, which induces conformational changes affecting the receptor's interaction with coactivators or corepressors. These interactions ultimately influence gene transcription and protein synthesis.
Its antagonistic activity on ERβ, contrasted with its agonist effect on ERα, makes it a powerful tool in molecular biology for identifying receptor-specific pathways and for testing hypotheses related to selective estrogen receptor modulators.
